Pain Persists in RA, Even Without Inflammation At 5 years, one-third of patients with rheumatoid arthritis still had "unacceptable" pain Jun 22, 2021
Osteoarthritis: A Link With Parkinson's? Inflammation may contribute to both joint and nerve degeneration Jun 09, 2021
Secukinumab Shows Promise for Kids With Arthritis More than 90% responded at week 12, study showed Jun 07, 2021
Rituximab a Hazard in RA Patients With COVID Poor outcomes were fourfold higher among rituximab users than for those on TNF inhibitors Jun 03, 2021
Methotrexate Impairs COVID Vax Response Can extra vaccine doses or discontinuing drug benefit patients with immune-mediated diseases? May 25, 2021
Plaque Psoriasis Drug Shows Promise for Psoriatic Arthritis Monoclonal antibody targets the IL-23 p19 subunit May 20, 2021
For Safety, One Biologic a Winner in Psoriasis, Psoriatic Arthritis Lower hospitalization rates compared with other biologics or small molecule therapies May 19, 2021
Stopping IL-17 Drug for Axial Spondyloarthritis? Expect Spinal Flares But low disease activity regained if treatment restarted May 11, 2021
The Death of One Little Girl Helped Millions A case more than 35 years ago has spurred discoveries ever since May 07, 2021 podcast
Results Disappoint for Fecal Transplant in Arthritis But interest persists in targeting the gut-joint axis in psoriatic arthritis May 04, 2021
Pegloticase Safe for Dialysis Patients With Gout Significant drop in monthly ESA dose seen after treatment, too Apr 09, 2021
For Enthesitis in Psoriatic Arthritis, Target IL-23 Targeted agent provides relief for many PsA patients Apr 08, 2021
JAK Inhibitor Promising in Psoriatic Arthritis Oral agent noninferior to adalimumab in joint symptoms Apr 01, 2021
FDA Panel Unhappy With Novel OA Pain Drug Latest setback for troubled osteoarthritis biologic Mar 25, 2021
Don't Stop Taltz in Psoriatic Arthritis Significantly more patients relapsed, and more quickly, after withdrawal Mar 10, 2021
JAK Inhibitor a Hit With RA Patients Superior to adalimumab on many patient-reported outcomes Feb 26, 2021
JAK Inhibitor Misses Endpoint in Safety Study. Now What? Major blow to popular class of oral rheumatology drugs Jan 27, 2021
PET Scans Reveal Vascular Inflammation In giant cell arteritis, imaging confirmed clinical response Jan 07, 2021
Spinal Benefits Seen With Cosentyx in PsA First trial to evaluate response of axial symptoms in psoriatic arthritis to biologic treatment Dec 22, 2020
TYK2 Inhibition Promising in Psoriatic Arthritis Phase II study found significant benefits for two doses of novel agent Nov 10, 2020
COVID Complications Common with Rheumatic Disease Adverse outcomes included acute kidney injury and congestive heart failure Nov 08, 2020
Rinvoq for RA: Benefits Persist Beyond 1 Year Manufacturer's extension study shows no loss of clinical response Nov 06, 2020
Military Burn Pits Linked With RA Seropositivity Highest risks for anti-CCP antibodies seen for smokers and those with the HLA-DRB1 shared epitope genes Oct 23, 2020
FDA Warns Against NSAIDs in Pregnancy After 20 Weeks Risk of kidney complications and low amniotic fluids may jeopardize fetus Oct 15, 2020
Upadacitinib, Abatacept Go Head to Head in RA And the winner is... both, depending on whether efficacy or safety is the main criterion Oct 14, 2020
Depression and Biologic Use in Arthritis: Chicken or Egg? Relationship appears to be bi-directional, researchers say Oct 02, 2020
Capsaicin Injection Improves Knee OA Pain Investigational treatment targets capsaicin receptor to inactivate local pain fibers Sep 06, 2020
Joint Effusion Protective in Hand OA Unlike synovitis, which was linked with both pain and progression Sep 03, 2020
Al Roker's Shoulder Replacement "Today" co-host and weatherman battles osteoarthritis pain Aug 25, 2020
Baricitinib and Infections: What's the Risk? Overall infections increased, but serious infections similar to placebo Aug 17, 2020
IL-1 Blockade: A Treatment at Last for Osteoarthritis? Canakinumab significantly lowered the risk of joint replacements in exploratory study Aug 03, 2020
Tocilizumab Raises GI Risks in Rheumatoid Arthritis Double the risk of one rare but potentially deadly event compared with use of TNF inhibitors, large Swedish study found Jul 22, 2020
Targeting IL-23 Relieves Multiple Symptoms in PsA Both enthesitis and dactylitis improved with guselkumab treatment in psoriatic arthritis Jul 21, 2020
Psoriatic Arthritis: Outcomes Similar for Cosentyx and Humira Primary endpoint of superiority for secukinumab over adalimumab not met in a phase IIIb trial Jun 08, 2020
Another IL-6 Blocker Succeeds in Rheumatoid Arthritis Effective in patients with moderately to severely active disease in a phase III trial Jun 03, 2020
EULAR 2020: What to Expect Cancelled due to pandemic but extensive menu of virtual learning planned Jun 02, 2020
Biologics Don't Increase Melanoma Risk... Probably Meta-analysis offers some reassurance, but leaves room for doubt May 20, 2020
IL-17A Blockers Succeed in Spine Disease Secukinumab and ixekizumab best placebo for ankylosing spondylitis May 13, 2020
Study Backs Cytokine Targeting for COVID-19 Tx Interrupting host inflammatory response shows promise May 08, 2020
